Literature DB >> 1422084

Oligodeoxyribonucleotide phosphorothioate fluxes and localization in hematopoietic cells.

G Marti1, W Egan, P Noguchi, G Zon, M Matsukura, S Broder.   

Abstract

An antisense oligonucleotide phosphorothioate, previously shown to inhibit HIV-1 viral expression in chronically infected H9 cells, was fluorescently labeled to study oligonucleotide fluxes and localization within living cells. Observations based on flow cytometry and fluorescence microscopy show the following: within around 0.5-2 h, an apparent steady-state distribution of the oligonucleotide is achieved in which the intracellular oligonucleotide concentration is less than that present in the external medium; following oligonucleotide uptake and resuspension of the cells in oligonucleotide-free medium, an oligonucleotide efflux, with a time constant similar to that for uptake, is observed (although a significant fraction of the phosphorothioate remains within the cell); cellular uptake as a function of the external oligonucleotide concentration is nonlinear, being more efficient at lower concentrations (less than 2 microM); and a predominant oligonucleotide localization within the cell nucleus and perinuclear organelles is observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422084     DOI: 10.1089/ard.1992.2.27

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN: 1050-5261


  5 in total

1.  Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells.

Authors:  J L Tonkinson; C A Stein
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

2.  Biological availability and nuclease resistance extend the in vitro activity of a phosphorothioate-3'hydroxypropylamine oligonucleotide.

Authors:  R C Tam; Y Li; S Noonberg; D G Hwang; G Lui; C A Hunt; M R Garovoy
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

3.  Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.

Authors:  R Bergan; Y Connell; B Fahmy; L Neckers
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

4.  Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.

Authors:  H Nakashima; Y Shoji; S G Kim; J Shimada; Y Mizushima; M Ito; N Yamamoto; H Takaku
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

Review 5.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.